Endoscopic management of biliary tract strictures in primary sclerosing cholangitis

Endoscopy

Volumn 28, Issue 7, 1996, Pages 546-551

  Wagner, S ^a   Gebel, M ^a   Meier, P ^a   Trautwein, C ^a   Bleck, J ^a   Nashan, B ^b   Manns, M P ^a,c  

^a Hochschule   (Germany)

^b Medizinische Hochschule Hannover ^*  (Germany)

^c HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; BILIRUBIN; GAMMA GLUTAMYLTRANSFERASE;

ADULT; ALKALINE PHOSPHATASE BLOOD LEVEL; ARTICLE; BILE DUCT; BILE DUCT OBSTRUCTION; BILIRUBIN BLOOD LEVEL; CLINICAL ARTICLE; ENDOSCOPY; FEMALE; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; HUMAN; MALE; PRIMARY SCLEROSING CHOLANGITIS; PRIORITY JOURNAL; PROSPECTIVE STUDY;

EID: 0029854054     PISSN: 0013726X     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-1005552     Document Type: Article

References (46)

1. Wiesner RH, Grambsch PM, Dickson ER, Ludwig J, MacCarty RL, Hunter EB, et al. Primary sclerosing cholangitis: natural history, prognostic factors and survival analysis. Hepatology 1989; 10: 430-6.
2. Lindor KD, Wiesner RH, MacCarty RL, Ludwig J, LaRusso NF. Advances in primary sclerosing cholangitis. Am J Med 1990; 89: 73-80.
3. Harrison RF, Hubscher SG. The spectrum of bile duct lesions in end-stage primary sclerosing cholangitis. Histopathology 1991; 19: 321-7.
4. Chapman RW. Aetiology and natural history of primary sclerosing cholangitis: a decade of progress? Gut 1991; 32: 1433-5.
5. Martin M. Primary sclerosing cholangitis. Ann Rev Med 1993; 44: 221-7.
6. Olsson R, Danielsson A, Jarnerot G, Lindstrom E, Loof L, Rolny P, et al. Prevalence of primary sclerosing cholangitis in patients with ulcerative colitis. Gastroenterology 1991; 100: 1319-23.
7. Mulder AH, Horst G, Haagsma EB, Kleibeuker JH, Kallenberg CG. Antineutrophil cytoplasmic antibodies (ANCA) in autoimmune liver disease. Adv Exp Med Biol 1993; 336: 545-9.
8. Mandal A, Dasgupta A, Jeffers L, Squillante L, Hyder S, Reddy R, et al. Autoantibodies in sclerosing cholangitis against a shared peptide in biliary and colon epithelium. Gastroenterology 1994; 106: 185-92.
9. Manns MP, Krüger M. Immunogenetics of chronic liver diseases. Gastroenterology 1994; 106: 1676-97.
10. Farrant JM, Hayllar KM, Wilkinson ML, Karani J, Portmann BC, Westaby D, et al. Natural history and prognostic variables in primary sclerosing cholangitis. Gastroenterology 1991; 100: 1710-7.
11. Dickson ER, Murtaugh PA, Wiesner RH, Grambsch PM, Fleming TR, Ludwig J, et al. Primary sclerosing cholangitis: refinement and validation of survival models. Gastroenterology 1992; 103: 1893-901.
12. Kilpe VE, Krakauer H, Wren RE. An analysis of liver transplant experience from 37 transplant centers as reported to Medicare. Transplantation 1993; 56: 554-61.
13. Abu Elmagd KM, Malinchoc M, Dickson ER, Fung JJ, Murtaugh PA, Langworthy AL, et al. Efficacy of hepatic transplantation in patients with primary sclerosing cholangitis. Surg Gynecol Obstet 1993; 177: 335-44.
14. Strasser S, Shell AG, Gallagher ND, Waugh R, McCaughan GW. Liver transplantation for primary sclerosing cholangitis versus primary biliary cirrhosis: a comparison of complications and outcome. J Gastroenterol Hepatol 1993; 8: 238-43.
15. Kaplan MM. Medical approaches to primary sclerosing cholangitis. Semin Liver Dis 1991; 11: 56-63.
16. O'Brien CB, Senior JR, Arora Mirchandani R, Batta AK, Salen G. Ursodeoxycholic acid for the treatment of primary sclerosing cholangitis: a 30-month pilot study. Hepatology 1991; 14: 838-47.
17. Beuers U, Spengler U, Kruis W, Aydemir U, Wiebecke B, Heldwein W, et al. Ursodeoxycholic acid for treatment of primary sclerosing cholangitis: a placebo-controlled trial. Hepatology 1992; 16: 707-14.
18. Lebovics E, Salama M, Elhosseiny A, Rosenthal WS. Resolution of radiographic abnormalities with ursodeoxycholic acid therapy of primary sclerosing cholangitis. Gastroenterology 1992; 102: 2143-7.
19. Gross JB Jr. Promises, promises: ursodeoxycholic acid for primary sclerosing cholangitis. Gastroenterology 1993; 104: 941-3.
20. Stiehl A, Walker S, Stiehl L, Rudolph G, Hofmann WJ, Theilmann L. Effect of ursodeoxycholic acid on liver and bile duct disease in primary sclerosing cholangitis: a 3-year pilot study with a placebo-controlled study period. J Hepatol 1994; 20: 57-64.
21. Javett SL. Azathioprine in primary sclerosing cholangitis. Lancet 1971; i: 810.
22. Schwartz SI. Primary sclerosing cholangitis: a disease revisited. Surg Clin North Am 1973; 53: 1161-8.
23. LaRusso NF, Weisner RH, Ludwig J, MacCarty RL, Beaver SJ, Zinsmeister AR. Prospective trial of penicillamine in primary sclerosing cholangitis. Gastroenterology 1988; 95: 1036-42.
24. Kaplan MM, Arora S, Pincus SH. Primary sclerosing cholangitis and low-dose oral pulse methotrexate therapy. Ann Intern Med 1987; 106: 231-5.
25. Knox TA, Kaplan MM. A double-blind controlled trial of oralpulse methotrexate therapy in the treatment of primary sclerosing cholangitis. Gastroenterology 1994; 106: 494-9.
26. Pift HA, Thompson HH, Tompkins RK, Longmire WP. Primary sclerosing cholangitis: results of an aggressive approach. Ann Surg 1982; 196: 259-68.
27. Thompson JS, Wood RP, Burnett DA, Shaw BW, Rikkers LF. The role of nontransplant procedures for sclerosing cholangitis. Am J Surg 1988; 156: 506-8.
28. Lillemoe KD, Cameron JL. Surgical approaches to primary sclerosing cholangitis. Semin Liver Dis 1991; 11: 49-55.
29. Ismail T, Angrisani I, Powell JE, Hübscher S, Buckels J, Neuberger J, et al. Primary sclerosing cholangitis: surgical options, prognostic variables and outcome. Br J Surg 1991; 78: 564-7.
30. May OR, Bender CE, LaRusso NF, Wiesner RH. Non-operative dilatation of dominant strictures in primary sclerosing cholangitis. Am J Radiol 1985; 145: 1061-4.
31. Skolkin MD, Alspaugh JP, Casarella WJ, Chuang VP, Galambos JT. Sclerosing cholangitis: palliation with percutaneous cholangioplasty. Radiology 1989; 170: 199-206.
32. Cotton PB, Nicki N. Endoscopic and radiologic approaches to therapy in primary sclerosing cholangitis. Semin Liver Dis 1991; 11: 40-8.
33. Lombard M, Farrant M, Karani J, Westaby D, Williams R. Improving biliary-enteric drainage in primary sclerosing cholangitis: experience with endoscopic methods. Gut 1991; 32: 1364-8.
34. Johnson GK, Geenen JE, Venu RP, Schmalz MJ, Hogan WJ. Endoscopic treatment of biliary tract strictures in sclerosing cholangitis: a larger series and recommendations for treatment. Gastrointest Endosc 1991; 37: 38-43.
35. Gaing AA, Geders JM, Cohen SA, Siegel JH. Endoscopic management of primary sclerosing cholangitis: review, and report of an open series. Am J Gastroenterol 1993; 88: 2000-8.
36. Cairns SR, Cotton PB. Potential for therapy in primary sclerosing cholangitis. Gut 1987; 28: A1342.
37. Craig DA, MacCarty RL, Wiesner RH, Grambsch PM, LaRusso NF. Primary sclerosing cholangitis: value of cholangiography in determining the prognosis. Am J Roentgenol 1991; 157: 959-64.
38. Lee JG, Schutz SM, England RE, Leung JW, Cotton PB. Endoscopic therapy of sclerosing cholangitis. Hepatology 1995; 21: 661-7.
39. Wood RAB, Cuschieri A. Is sclerosing cholangitis complicating ulcerative colitis a reversible condition? Lancet 1980; ii: 716-8.
40. Russel E, Yrizarry JM, Huber JS, Nunez D, Hutson DG, Schiff E, et al. Percutaneous transjejunal biliary dilatation: alternative management for benign strictures. Radiology 1986; 159: 209-14.
41. Cameron JL, Pitt HA, Zinner MJ, et al. Resection of hepatic duct bifurcation and transhepatic stenting for sclerosing cholangitis. Ann Surg 1988; 207: 614-22.
42. Mueller PR, van Sonnenberg E, Ferruci JT, et al. Biliary stricture dilatation: multicentre review of clinical management in 73 patients. Radiology 1986; 160: 17-22.
43. Hamilton I, Soutar JS, Bouchier IA, Cuschieri A. Short-term biliary dilatation and stenting in primary sclerosing cholangitis. J Clin Gastroenterol 1987; 9: 70-5.
44. Huibregtse K. Therapeutic investigations in primary sclerosing cholangitis. In: Huibregtse K. Endoscopic biliary and pancreatic drainage. Stuttgart: Thieme, 1988: 78-85.
45. Gebel M, Wagner S, Manns MP. Minicholangioscopy improves diagnostic efficiency of ERCP in biliary duct stenosis. Gastrointest Endosc 1993; 39: 64.
46. Nashan B, Schlitt HJ, Tusch G, Oldhafer KJ, Ringe B, Wagner S, et al. Biliary malignancies in primary sclerosing cholangitis: timing for liver transplantation. Hepatology 1996; 23: 1105-11.